IOVA
USDIovance Biotherapeutics Inc. Common Stock
$2.300+0.050 (2.222%)
即時價格
Healthcare
生物科技
美國
價格圖表
Loading Chart...
關鍵指標
市場指標
開盤
$2.250
最高
$2.380
最低
$2.080
交易量
17.39M
公司基本面
市值
913.0M
行業
生物科技
國家
United States
交易統計
平均交易量
13.73M
交易所
NGM
貨幣
USD
52週範圍
最低 $1.64當前 $2.300最高 $10.86
相關新聞
GlobeNewswire
Iovance Biotherapeutics Reports Potential Best-in-Class Clinical Data for Lifileucel TIL Cell Therapy in Advanced Non-Small Cell Lung Cancer (NSCLC)
26% Objective Response Rate Median Duration of Response Not Reached after 25 Months Follow Up Lifileucel Launch in Previously Treated Advanced NSCLC Expected in Second Half of 2027 SAN CARLOS, Calif., Nov. 03, 2025
查看更多
Analyst Upgrades
HC Wainwright & Co. Maintains Buy on Iovance Biotherapeutics, Lowers Price Target to $9
HC Wainwright & Co. analyst Joseph Pantginis maintains Iovance Biotherapeutics with a Buy and lowers the price target from $20 to $9.
查看更多
